NCT06986837View on ClinicalTrials.gov

Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

February 5, 2023

Study Completion Date

April 20, 2024

Conditions
Sickle Cell Disease
Trial Locations (1)

97159

Chu de La Guadeloupe, Pointe-à-Pitre

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Guadeloupe

OTHER

NCT06986837 - Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient | Biotech Hunter | Biotech Hunter